Dynamic Technology Lab’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Dynamic Technology Lab’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-10,542	Closed	-$42K	–	1647
2022 Q2	$42K	Buy	+10,542	New	+$50K	﹤0.01%	1035
2022 Q1	–	Sell	-27,844	Closed	-$156K	–	1650
2021 Q4	$156K	Buy	+27,844	New	+$177K	0.02%	1000
2021 Q3	–	Sell	-15,151	Closed	-$128K	–	1582
2021 Q2	$128K	Sell	15,151 -9,654	-39%	-$77.9K	0.01%	979
2021 Q1	$260K	Buy	+24,805	New	+$349K	0.03%	845
2020 Q3	–	Sell	-24,065	Closed	-$340K	–	1437
2020 Q2	$340K	Buy	+24,065	New	+$304K	0.05%	629

Other funds holding PRVB

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dynamic Technology Lab's PRVB Position: Q3 2022 in Review

Dynamic Technology Lab sold out of Provention Bio, Inc. Common Stock (PRVB) in Q3 2022, closing a stake of 10,542 shares — an estimated $42K sold.

Dynamic Technology Lab first reported a position in PRVB in Q2 2020 and held it in 5 quarters. The position peaked at $340K in Q2 2020. 112 funds tracked by Wall St. Rank hold PRVB as of Q3 2022.

Dynamic Technology Lab reported no remaining Provention Bio, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Dynamic Technology Lab sold 10,542 Provention Bio, Inc. Common Stock shares in Q3 2022, an estimated $42K.
Dynamic Technology Lab first reported a position in Provention Bio, Inc. Common Stock in Q2 2020 and held it in 5 quarters.
Dynamic Technology Lab's Provention Bio, Inc. Common Stock position peaked at $340K in Q2 2020.
112 funds tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q3 2022.

Based on Dynamic Technology Lab's 13F filing for Q3 2022, filed 14 Nov 2022.